Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,528 | -17,595 | 2,037 | -8,486 | -5,143 |
| Depreciation Amortization | 3,710 | 3,485 | 3,898 | 2,774 | 1,828 |
| Other Working Capital | 1,868 | -574 | 2,697 | 385 | 791 |
| Operating Cash Flow | $-15,950 | $-14,684 | $8,632 | $-5,327 | $-2,524 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,078 | -1,910 | -1,839 | -1,454 | -1,248 |
| Other Investing Activity | -25,939 | -12,194 | 8,526 | -7,953 | -23,974 |
| Investing Cash Flow | $-29,017 | $-14,104 | $6,687 | $-9,407 | $-25,222 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,714 | 71,854 | 1,617 | -1,220 | 50,906 |
| Financing Cash Flow | $1,714 | $71,854 | $1,617 | $-1,220 | $50,906 |
| Exchange Rate Effect | 0 | 2 | N/A | N/A | N/A |
| Beginning Cash Position | 71,643 | 28,575 | 11,639 | 27,593 | 4,433 |
| End Cash Position | 28,390 | 71,643 | 28,575 | 11,639 | 27,593 |
| Net Cash Flow | $-43,253 | $43,068 | $16,936 | $-15,954 | $23,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,950 | -14,684 | 8,632 | -5,327 | -2,524 |
| Free Cash Flow | -15,950 | -14,684 | 8,632 | -5,327 | -2,524 |